Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Rxi Pharmaceuticals Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Rxi Pharmaceuticals Corp (RXII-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for RXII

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

30 Oct 2016 ValuEngine, Inc. 11 $25.00

RXI PHARMACEUTICALS CP (RXII=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

29 Oct 2016 Pechala's Reports 2 $25.00

RXi Pharmaceuticals - Expanding into immuno-oncology

RXi recently announced that it has entered into an exclusive option agreement to acquire MirImmune, an early-stage private co...

25 Oct 2016 Edison Investment Research 6 $10.00

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review Summary RXi Pharmaceuticals Corporation (RXi) is a biotech...

17 Oct 2016 GlobalData 57 $300.00

New Deal to Open the Oncology Market

12 Oct 2016 Griffin Securities, Inc. 7 $46.00

Wright Investors Service Comprehensive Report for RXi Pharmaceuticals Corp

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

07 Oct 2016 Wright Reports 63 $75.00

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review

RXi Pharmaceuticals Corporation (RXII) - Financial Analysis Review Summary RXi Pharmaceuticals Corporation (RXi) is a biotech...

13 Sep 2016 GlobalData 53 $300.00

Myriad of New Data Coming Soon

22 Aug 2016 Griffin Securities, Inc. 14 $115.00